The purpose of this study is to test the hypothesis that the HumaPen Memoir...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Clinical Trial to Evaluate The Effects of Semaglutide and Empagliflozin Combined to Automated Insulin Delivery on Diabetes Control in Adults Living With Type 1 Diabetes
PHASE3
The goal of this clinical trial is to learn if Empagliflozin and Semaglutid...
Status
Recruiting
Location
Research Institute of the McGill University Health Centre
A Study to Evaluate the Effectiveness and Safety Initiation and Titration of Insulin Glargine (U300) in Insulin-naïve Patients With Type 2 Diabetes Mellitus (T2DM) Controlled on Oral Antidiabetic Drug Treatment in Turkey
PHASE4
Primary Objective:
To assess the mean change in HbA1c (glycated haemoglobi...